Antimicrobial Agents and Chemotherapy · 2003 · 249 citations · 35 references
Life SciencesBiochemistryProtein BiochemistryStructural BiochemistryStructural BiologyAmino Acid ChemistryAntibacterial AgentsAntimicrobial PeptidesPeptide ChemistryProtein StructureAntibacterial PeptidesAntimicrobial Peptide ActivityAntimicrobial PropertiesDefensin FamilyNative Disulfide Bond FormationNon-native Disulfide Bond FormationPeptide Structure - Activity RelationshipsPeptide Structure-activity Relationships
Human beta-defensin 3 (hBD3) is a highly basic 45-amino-acid protein that acts both as an antimicrobial agent and as a chemoattractant molecule. Although the nature of its antimicrobial activity is largely electrostatic, the importance of the molecular structure on this activity is poorly understood. Two isoforms of hBD3 were synthesized: the first with native disulfide linkages and the second with nonnative linkages. In a third synthetic peptide, all cysteine residues were replaced with alpha-aminobutyric acid, creating a completely linear peptide. A series of six small, linear peptides corresponding to regions of hBD3 with net charges ranging from +4 to +8 (at pH 7) and lengths ranging from 9 to 20 amino acids were also synthesized. The linear full-length peptide showed the highest microbicidal activity against Escherichia coli and Staphylococcus aureus, while all three full-length forms showed equal activity against Candida albicans. The linear peptide also showed high activity against Enterococcus faecium and Pseudomonas aeruginosa. Peptides corresponding to the C terminus showed higher activities when tested against E. coli, with the most active peptides being the most basic. However, only the peptide corresponding to the N terminus of hBD3 showed any activity against S. aureus and C. albicans. Further, N-terminal deletion mutants of native hBD3 showed diminished activities against S. aureus. Thus, the antimicrobial properties of hBD3 derivatives are determined by both charge and structure.
35
Defensins. Natural peptide antibiotics of human neutrophils.
Tomas Ganz, Michael E. Selsted, D Szklarek et al. · Journal of Clinical Investigation · 1985 · 1.4K citations · Full text
Andreas Peschel, Michaël Otto, Ralph W. Jack et al. · Journal of Biological Chemistry · 1999 · 993 citations · Full text